<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03371082</url>
  </required_header>
  <id_info>
    <org_study_id>GL-GLAT1-3001</org_study_id>
    <nct_id>NCT03371082</nct_id>
  </id_info>
  <brief_title>Gan &amp; Lee Insulin Glargine Target Type (1) Evaluating Research</brief_title>
  <acronym>GLITTER 1</acronym>
  <official_title>AN OPEN-LABEL, RANDOMIZED, MULTICENTER, PHASE III STUDY TO COMPARE THE IMMUNOGENICITY, EFFICACY, AND SAFETY OF GAN &amp; LEE PHARMACEUTICALS INSULIN GLARGINE INJECTION TO LANTUS® IN ADULT SUBJECTS WITH TYPE 1 DIABETES MELLITUS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gan and Lee Pharmaceuticals, USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gan and Lee Pharmaceuticals, USA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary Objective:

        -  To demonstrate equivalence of Gan &amp; Lee Insulin Glargine Injection and Lantus® in terms
           of immunogenicity

      Secondary Objective:

        -  Immunogenicity: To evaluate the percentage of subjects with negative anti-insulin
           antibodies (AIA) at baseline who develop confirmed positive AIA up to Week 26
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2017</start_date>
  <completion_date type="Anticipated">January 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Subjects who meet the study eligibility criteria will be centrally randomized 1:1 in an open-label fashion to receive either Gan &amp; Lee Insulin Glargine Injection or Lantus® for 26 weeks. Randomization will be stratified by country.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immunogenicity</measure>
    <time_frame>Up to Week 26</time_frame>
    <description>The percentage of subjects in each treatment group who develop treatment-induced AIA up to Week 26</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <arm_group>
    <arm_group_label>Gan &amp; Lee Insulin Glargine Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Gan &amp; Lee Insulin Glargine Injection for subcutaneous injection, 100 U/mL, in the integrated, disposable 3.0-mL prefilled Gan &amp; Lee injector pen. Subjects randomized to the Gan &amp; Lee Insulin Glargine Injection group will participate in the study for 26 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lantus®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lantus® solution for subcutaneous injection, 100 U/mL, in the SoloStar® 3.0 mL prefilled insulin pen. Subjects randomized to the Lantus® group will participate for 26 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Gan &amp; Lee Insulin Glargine Injection</intervention_name>
    <description>Route of administration: subcutaneous injection</description>
    <arm_group_label>Gan &amp; Lee Insulin Glargine Injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Lantus®</intervention_name>
    <description>Route of administration: subcutaneous injection</description>
    <arm_group_label>Lantus®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 Diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Watters, MA MB BAO BCh</last_name>
    <role>Study Director</role>
    <affiliation>Gan &amp; Lee Pharmaceuticals USA Corporation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elena A. Christofides, MD FACE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Endocrinology Associates, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gan &amp; Lee Pharmaceuticals, USA</last_name>
    <phone>844.218.5504</phone>
    <email>ClinicalTrials@GanLee.US</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Ovalle, MD</last_name>
      <phone>205-934-4112</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Valley Research</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul C Norwood, MD</last_name>
      <phone>512-453-0310</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Rose Salter Medical Research Foundation</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Rendell, MD</last_name>
    </contact>
    <contact_backup>
      <phone>949.887.5022</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>California Medical Research Association</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Robinson, MD</last_name>
      <phone>818-349-1979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Metabolic Institute of America</name>
      <address>
        <city>Tarzana</city>
        <state>California</state>
        <zip>91356</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yehuda Handelsman, MD</last_name>
      <phone>818-708-9942</phone>
      <email>info@tmioa.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CMR of Greater New Haven, LLC</name>
      <address>
        <city>Hamden</city>
        <state>Connecticut</state>
        <zip>06517</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Mayerson, MD</last_name>
      <phone>203-419-4404</phone>
      <email>Medical_research@chasemr.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Meridien Research</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Chaykin, MD</last_name>
      <phone>941-756-8680</phone>
      <email>mbell@meridienresearch.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Center for Diabetes and Endocrine Care</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33312</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sam Lerman, MD</last_name>
      <phone>954-963-7100</phone>
      <email>xyz@diabetes-endocare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Homestead Associates in Research</name>
      <address>
        <city>Homestead</city>
        <state>Florida</state>
        <zip>33032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gillberto Seco, MD</last_name>
    </contact>
    <contact_backup>
      <phone>305.246.0873</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Central Florida Endocrine and Diabetes Consultants - Maitland</name>
      <address>
        <city>Maitland</city>
        <state>Florida</state>
        <zip>32751</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny Glickman, MD</last_name>
    </contact>
    <contact_backup>
      <phone>407.629.4901</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Biotech Pharmaceutical Group, LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrique De La Torre, MD</last_name>
      <phone>786-353-9711</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>New Horizon Research Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33175</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Miranda, MD</last_name>
      <phone>305-226-3933</phone>
      <email>info@nhorizonresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Miami Dade Medical Research Institute, LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orlando Puente, MD</last_name>
      <phone>305-722-7210</phone>
      <email>ofajardo@miamimedresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Suncoast Clinical Research, Inc.</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <zip>34652</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy Barnes</last_name>
      <phone>727-849-4131</phone>
      <email>info@suncoastclinicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peninsula Research</name>
      <address>
        <city>Ormond Beach</city>
        <state>Florida</state>
        <zip>32174</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnold Vera, MD MSC FACE CDE</last_name>
      <phone>386-677-0525</phone>
      <email>information@pri-fl.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oviedo Medical Research, LLC</name>
      <address>
        <city>Oviedo</city>
        <state>Florida</state>
        <zip>32765</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bradley M Block, MD</last_name>
      <phone>407-977-2705</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Metabolic Research Institute, Inc.</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barry S Horowitz, MD, FACP</last_name>
      <phone>561-802-3060</phone>
      <email>info@mri-news.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>River Birch Research Alliance, LLC</name>
      <address>
        <city>Blue Ridge</city>
        <state>Georgia</state>
        <zip>30513</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond Tidman, MD</last_name>
      <phone>706-258-4184</phone>
      <email>info@riverbirch.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>iResearch Atlanta</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimball A Johnson, MD</last_name>
      <phone>404-537-1281</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sestron Clinical Research</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Glenn Gatipon, MD, PHD, MBA</last_name>
      <phone>770-795-7905</phone>
      <email>stirillo@sestron.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Endocrine Research Solutions, Inc.</name>
      <address>
        <city>Roswell</city>
        <state>Georgia</state>
        <zip>30076</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John H. Reed, MD, CDA</last_name>
      <phone>678-878-4750</phone>
      <email>Endoresearch@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>East-West Medical Research Institute</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96814</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Fitz-Patrick, MD</last_name>
      <phone>808-440-4426</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Clinical Research - Idaho</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark A Turner, MD</last_name>
      <phone>208-377-8653</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cedar Crosse Research Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danny Sugimoto, MD, CPI</last_name>
      <phone>312-431-6780</phone>
      <email>info@cedarcrosse.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John H. Stroger Jr. Hospital of Cook County</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leon Fogelfeld, MD</last_name>
      <phone>312-864-0537</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Midwest CRC</name>
      <address>
        <city>Crystal Lake</city>
        <state>Illinois</state>
        <zip>60012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiralal Maheshwari</last_name>
      <phone>815-444-6362</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Iowa Diabetes and Endocrinology Research Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anuj Bhargava, MD</last_name>
      <phone>515-235-5000</phone>
      <email>research@iderc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kentucky Diabetes Endocrinology Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503-1473</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyle C. Myers, MD</last_name>
      <phone>859-278-2232</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Palm Research Center, Inc.</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89418</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samer Nakhle, MD</last_name>
    </contact>
    <contact_backup>
      <phone>702-826-2795</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Physicians East, PA</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Warren, MD</last_name>
      <phone>252-752-6101</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lillestol Research LLC</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael J Lillestol, MD</last_name>
      <phone>866-532-7705</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Endocrinology Associates, Inc.</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena A. Christofides, MD, FACE</last_name>
      <phone>614-824-5865</phone>
      <email>research@endocrinology-associates.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aventiv Research, Inc.</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43213-6523</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samir Arora, MD</last_name>
      <phone>614-532-4458</phone>
      <email>info@aventivresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>PriMed Clinical Research</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45419</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William J Randall, MD</last_name>
      <phone>937-534-4201</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Diabetes &amp; Endocrine Consultants</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37411</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Huffman, MD</last_name>
      <phone>423-265-3561</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>ClinSearch - Clinical Research Specialists</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37421</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark McKenzie, MD</last_name>
      <phone>423-698-4584</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>New Phase Research &amp; Development</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelyne M Davidson, MD</last_name>
      <phone>865-200-8364</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Diabetes &amp; Endocrinology - Central Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas L Blevins, MD</last_name>
      <phone>512-334-3505</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Diabetes &amp; Endocrinology - South Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78749</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsay Harrison, MD</last_name>
      <phone>512-334-3505</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Research Institute of Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Aronoff, MD</last_name>
      <phone>214-265-2137</phone>
      <email>research@researchdallas.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Diabetes &amp; Endocrinology</name>
      <address>
        <city>Round Rock</city>
        <state>Texas</state>
        <zip>78681</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerem Ozer, MD</last_name>
      <phone>512-458-8400</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of Texas</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas S Denham, DO</last_name>
      <phone>210-949-0122</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northeast Clinical Research of San Antonio</name>
      <address>
        <city>Schertz</city>
        <state>Texas</state>
        <zip>78154</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Akright, MD</last_name>
      <phone>210-581-0045</phone>
      <email>info@necrsa.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radiant Research</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael R Adams, MD</last_name>
      <phone>801-261-8930</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Research Institute</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jack D Wahlen, MD PhD</last_name>
      <phone>801-409-2040</phone>
      <email>info@advresearch.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wasatch Clinical Research, LLC</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael D. Killpack, MD</last_name>
      <phone>818-708-9942</phone>
      <email>info@tmioa.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Burke Internal Medicine</name>
      <address>
        <city>Burke</city>
        <state>Virginia</state>
        <zip>22105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nashwa W Gabra, MD</last_name>
      <phone>703-250-5171</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stonesifer Clinical Research</name>
      <address>
        <city>Federal Way</city>
        <state>Washington</state>
        <zip>98003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Larry D. Stonesifer, MD, FACP, FACE</last_name>
      <phone>253.815.6880</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rainier Clinical Research Center, Inc.</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Brazg, MD, FACE</last_name>
      <phone>425-251-1720</phone>
      <email>rcrc@rainier-research.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MultiCare Institute for Research &amp; Innovation</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald J Graf, MD</last_name>
      <phone>253-403-1000</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2017</study_first_submitted>
  <study_first_submitted_qc>December 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2017</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Diabetes Type 1</keyword>
  <keyword>Type 1</keyword>
  <keyword>Basal</keyword>
  <keyword>Insulin</keyword>
  <keyword>Glargine</keyword>
  <keyword>T1DM</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Insulin Dependent Diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin Glargine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

